Key result
COVID-19 vaccination is linked to rare but serious cardiovascular complications, notably myocarditis and thrombosis.
Why the study?
Reports of vaccine-related adverse cardiovascular events after COVID-19 vaccination are gradually increasing, with serious complications observed in some populations.
May prompt heightened post-vaccination surveillance in vulnerable patients; leaves open causality and incidence in larger cohorts.
With the global popularization of vaccination against coronavirus disease 2019 (COVID-19), the reports of cases of vaccine-related adverse events are gradually increasing. The most common events are local pain at the injection site and atypical symptoms, such as fever, headache, myalgia, and general discomfort. However, a few people might develop serious cardiovascular complications, such as myocarditis, coronary spasm, and thrombosis. Elderly people and adolescents should be more alert to vaccine-related cardiovascular adverse events due to their underlying chronic comorbidities or compromised immune systems.
No takes yet. Share an insight, caveat, or question.
Han et al. (2021) conducted a review in Adverse cardiovascular events following COVID-19 vaccination. COVID-19 vaccination was evaluated. Rare but serious cardiovascular complications such as myocarditis and thrombosis have been reported following COVID-19 vaccination, warranting clinical vigilance in vulnerable populations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: